ArticleBioengineered2022

Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2.

Yue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.